Molecular similarity considerations in the licensing of orphan drugs.
Sign Up to like & getrecommendations! Published in 2017 at "Drug discovery today"
DOI: 10.1016/j.drudis.2016.11.024
Abstract: The large costs associated with modern drug discovery mean that governments and regulatory bodies need to provide economic incentives to promote the development of orphan drugs (i.e., medicinal products that are designed to treat rare… read more here.
Keywords: licensing orphan; similarity; similarity considerations; orphan drugs ... See more keywords